Edgewise Shares Rally In Morning Trade

(RTTNews) - Shares of Edgewise Therapeutics, Inc. (EWTX) are surging more than 40% in Friday morning trade.

The company has announced pricing 21,818,182 of its shares at $11 per share. It intends to use the proceeds to support the potential U.S. commercial launch of EDG-5506 in patients with Becker muscular dystrophy, completion of Phase 2 trials of EDG-7500 in patients with hypertrophic cardiomyopathy, among others.

EDG-5506 is in clinical trials in patients with Becker, Duchenne, and Limb-Girdle muscular dystrophies as well as McArdle Disease. EDG-7500 is currently in a Phase 1 trial.

EWTX is at $13.58 currently. It has traded in the range of $5.12 - $13.32 in the last 1 year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.